John Ransom
Stock Analyst at Raymond James
(4.68)
# 184
Out of 4,667 analysts
226
Total ratings
64.75%
Success rate
18.25%
Average return
Main Sectors:
Stocks Rated by John Ransom
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SCI Service Corporation International | Maintains: Outperform | $80 → $85 | $85.42 | -0.49% | 12 | Nov 1, 2024 | |
| THC Tenet Healthcare | Maintains: Strong Buy | $130 → $175 | $151.84 | +15.25% | 16 | Jul 25, 2024 | |
| GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $4.31 | +132.02% | 2 | May 16, 2024 | |
| RDNT RadNet | Maintains: Outperform | $50 → $60 | $82.16 | -26.97% | 10 | May 10, 2024 | |
| EHC Encompass Health | Reiterates: Strong Buy | $85 → $95 | $98.93 | -3.97% | 15 | Apr 26, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Market Perform | n/a | $8.24 | - | 7 | Mar 26, 2024 | |
| AMED Amedisys | Maintains: Market Perform | n/a | $90.00 | - | 14 | Mar 26, 2024 | |
| HUM Humana | Initiates: Market Perform | n/a | $293.97 | - | 1 | Mar 22, 2024 | |
| OSCR Oscar Health | Initiates: Outperform | $20 | $17.00 | +17.65% | 1 | Mar 22, 2024 | |
| PHR Phreesia | Reiterates: Outperform | $25 → $30 | $18.52 | +61.99% | 12 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $330 | $333.00 | -0.90% | 20 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $16 | $3.56 | +349.44% | 3 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $11.95 | +0.42% | 9 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $310 → $330 | $323.39 | +2.04% | 16 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $56.83 | +49.57% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $120.99 | -13.22% | 8 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $6.35 | +57.48% | 4 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.77 | - | 7 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $7.36 | - | 11 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $22.23 | - | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $630 | $600.50 | +4.91% | 12 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $85 → $100 | $39.10 | +155.75% | 8 | Aug 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $3.83 | - | 7 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $51.82 | - | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $31.30 | - | 2 | Dec 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $161.40 | - | 8 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $59.00 | - | 3 | Mar 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $22.51 | - | 2 | Aug 9, 2017 |
Service Corporation International
Nov 1, 2024
Maintains: Outperform
Price Target: $80 → $85
Current: $85.42
Upside: -0.49%
Tenet Healthcare
Jul 25, 2024
Maintains: Strong Buy
Price Target: $130 → $175
Current: $151.84
Upside: +15.25%
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $4.31
Upside: +132.02%
RadNet
May 10, 2024
Maintains: Outperform
Price Target: $50 → $60
Current: $82.16
Upside: -26.97%
Encompass Health
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $98.93
Upside: -3.97%
Walgreens Boots Alliance
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $8.24
Upside: -
Amedisys
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $90.00
Upside: -
Humana
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $293.97
Upside: -
Oscar Health
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $17.00
Upside: +17.65%
Phreesia
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $18.52
Upside: +61.99%
Jan 31, 2024
Maintains: Outperform
Price Target: $300 → $330
Current: $333.00
Upside: -0.90%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $16
Current: $3.56
Upside: +349.44%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $11.95
Upside: +0.42%
Aug 7, 2023
Maintains: Strong Buy
Price Target: $310 → $330
Current: $323.39
Upside: +2.04%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $56.83
Upside: +49.57%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $120.99
Upside: -13.22%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $6.35
Upside: +57.48%
May 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $5.77
Upside: -
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $7.36
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $22.23
Upside: -
Apr 17, 2023
Maintains: Strong Buy
Price Target: $630
Current: $600.50
Upside: +4.91%
Aug 1, 2022
Maintains: Strong Buy
Price Target: $85 → $100
Current: $39.10
Upside: +155.75%
Feb 20, 2020
Upgrades: Market Perform
Price Target: n/a
Current: $3.83
Upside: -
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $51.82
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $31.30
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $161.40
Upside: -
Mar 21, 2018
Upgrades: Outperform
Price Target: n/a
Current: $59.00
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $22.51
Upside: -